Table 2.
Summary of studies showing role of bacterial metabolites on nervous health and behavior
| Bacterial metabolite | Class | Study Model | Host response | Reference |
|---|---|---|---|---|
|
| ||||
| CDCA and DCA | Bile Acid | BA injection in Sprague Dawley rats | Increased BBB permeability | (Quinn et al. 2014) |
| Obeticholic acid (OCA) | Bile Acid | Oral gavage of BA in HFHS (high fat, high sugar) fed mice | Improve metabolic disorder driven Anxiety | (Wu et al. 2021) |
| Sodium propionate, sodium butyrate and sodium acetate | SCFA | Added to drinking water in mice | Increased microglial maturation and function | (Erny et al. 2015) |
| Sodium butyrate | SCFA | BTBR autism mouse model | Attenuates social behavior deficits | (Kratsman et al. 2016) |
| Sodium butyrate | SCFA | Chronic mild stress model in Wistar rats | Anti-depressant and anti-manic properties | (Resende et al. 2013) |
| Propionate | SCFA | Experimental autoimmune encephalomyelitis | Ameliorate experimental autoimmune encephalomyelitis (EAE) disease course | (Haghikia et al. 2015) |
| P-cresol | Aromatic acid metabolite | BTBR autism mouse model | Triggers anxiety and hyperactivity at lower doses and exacerbate autism like behavior at higher dose | (Pascucci et al. 2020) |
| TMAO | Amine oxide | C57Bl/6 mice on low-choline diet supplemented with TMAO | Induced neuroinflammation and decline in cognitive function | (Brunt et al. 2021) |
| Tryptophan | Amino acid | EAE mouse model of multiple sclerosis | Decreased neuroinflammation and decreased EAE score | (Rothhammer et al. 2016) |